Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1970 1
1971 1
1972 1
1974 1
1975 1
1976 1
1977 1
1978 2
1979 2
1985 1
1986 2
1988 2
1989 3
1990 3
1991 4
1992 3
1993 5
1994 2
1995 5
1996 13
1997 8
1998 4
1999 13
2000 20
2001 23
2002 34
2003 40
2004 57
2005 60
2006 75
2007 117
2008 126
2009 154
2010 178
2011 211
2012 202
2013 176
2014 238
2015 260
2016 310
2017 321
2018 304
2019 291
2020 315
2021 338
2022 335
2023 329
2024 371
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,444 results

Results by year

Filters applied: . Clear all
Page 1
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.
Park SJ, Ahn JM, Kang DY, Yun SC, Ahn YK, Kim WJ, Nam CW, Jeong JO, Chae IH, Shiomi H, Kao HL, Hahn JY, Her SH, Lee BK, Ahn TH, Chang KY, Chae JK, Smyth D, Mintz GS, Stone GW, Park DW; PREVENT Investigators. Park SJ, et al. Among authors: yun sc. Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8. Lancet. 2024. PMID: 38604213 Clinical Trial.
Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease.
Cho MS, Kang DY, Ahn JM, Yun SC, Oh YS, Lee CH, Choi EK, Lee JH, Kwon CH, Park GM, Choi HO, Park KH, Park KM, Hwang J, Yoo KD, Cho YR, Kim JH, Hwang KW, Jin ES, Kwon O, Kim KH, Park SJ, Park DW, Nam GB; EPIC-CAD Investigators. Cho MS, et al. Among authors: yun sc. N Engl J Med. 2024 Dec 5;391(22):2075-2086. doi: 10.1056/NEJMoa2407362. Epub 2024 Sep 1. N Engl J Med. 2024. PMID: 39225258 Clinical Trial.
Bioart.
Yetisen AK, Davis J, Coskun AF, Church GM, Yun SH. Yetisen AK, et al. Among authors: yun sh. Trends Biotechnol. 2015 Dec;33(12):724-734. doi: 10.1016/j.tibtech.2015.09.011. Trends Biotechnol. 2015. PMID: 26617334 Review.
Routine Functional Testing or Standard Care in High-Risk Patients after PCI.
Park DW, Kang DY, Ahn JM, Yun SC, Yoon YH, Hur SH, Lee CH, Kim WJ, Kang SH, Park CS, Lee BK, Suh JW, Yoon JH, Choi JW, Kim KS, Choi SW, Lee SN, Park SJ; POST-PCI Investigators. Park DW, et al. Among authors: yun sc. N Engl J Med. 2022 Sep 8;387(10):905-915. doi: 10.1056/NEJMoa2208335. Epub 2022 Aug 28. N Engl J Med. 2022. PMID: 36036496 Clinical Trial.
Tumor heterogeneity in muscle-invasive bladder cancer.
Kang HW, Kim WJ, Choi W, Yun SJ. Kang HW, et al. Among authors: yun sj. Transl Androl Urol. 2020 Dec;9(6):2866-2880. doi: 10.21037/tau.2020.03.13. Transl Androl Urol. 2020. PMID: 33457261 Free PMC article. Review.
4,444 results